MRP1 is primarily involved in drug efflux in various cancer cells (Lu et al., 2015) whereas NQO1 and SOD1 upregulation increases drug resistance making the prognosis even worse (Datta and Sinha, 2019). This evidence concerns the gene SOD1 and cancer.